Celiac Disease Blood Test Screening
For patients consuming gluten, measure serum IgA anti-tissue transglutaminase (IgA-tTG) antibodies along with total IgA levels as the primary screening approach. 1
Primary Serologic Testing Strategy
The optimal initial testing combination consists of:
- IgA anti-tissue transglutaminase (IgA-tTG) - the primary screening test
- Total serum IgA level - to identify IgA deficiency that would cause false-negative results
This two-test approach is superior to other serologic combinations and represents the current standard of care 1.
Critical Pre-Testing Requirement
Patients must be consuming a gluten-containing diet at the time of testing. If gluten has already been restricted, they need to consume 3-6 grams of gluten daily for at least 6 weeks before testing 1. Testing on a gluten-free diet will reduce sensitivity of both serology and biopsy, leading to false-negative results 2.
Algorithm for IgA Deficiency
Selective IgA deficiency (sIgAD) occurs in approximately 2-3% of celiac disease patients - roughly 10-15 times more common than in the general population. When total IgA is low or undetectable:
- Switch to IgG-based testing: Measure IgG anti-tissue transglutaminase (IgG-tTG) or IgG anti-deamidated gliadin peptides (IgG-DGP) 1, 2
- Proceed with upper endoscopy and duodenal biopsies 1
Important caveat: IgG-tTG testing is NOT specific in patients with normal IgA levels and should not be used for routine screening 2.
Tests NOT Recommended for Initial Screening
- IgG anti-deamidated gliadin peptides (DGP-IgG/IgA) - not recommended for initial testing 1
- IgA anti-endomysial antibodies (EMA-IgA) - while highly specific, this is an immunofluorescence test that is more labor-intensive and should be reserved for confirmatory testing in specific scenarios (such as the no-biopsy pathway when IgA-tTG ≥10× upper limit of normal) 1, 3
Interpretation Framework
The diagnostic accuracy varies by result pattern:
- Positive IgA-tTG: Likelihood ratio for celiac disease ranges from 20-115 depending on the assay 4
- IgA-tTG ≥10× upper limit of normal: In symptomatic adults in secondary care, this can support a no-biopsy diagnosis if confirmed with positive EMA-IgA on a second sample 1, 2
- Negative IgA-tTG with normal total IgA: Likelihood ratio ≤0.12, effectively ruling out celiac disease in most cases 4
Next Steps After Positive Serology
All patients with positive celiac serology should be referred to a gastroenterologist or specialist for confirmation before starting a gluten-free diet 1. The diagnosis typically requires:
- At least 4 biopsies from the second part of the duodenum (D2)
- At least 2 biopsies from the duodenal bulb (D1)
- Histologic confirmation showing increased intraepithelial lymphocytes (>25/100 epithelial cells) plus crypt hyperplasia with or without villous atrophy (Marsh 2-3) 1
Common Pitfalls to Avoid
Testing patients already on a gluten-free diet - this is the most common error leading to false-negative results 2
Using IgG-tTG in patients with normal IgA levels - this lacks specificity and generates false positives 2
Ordering anti-DGP antibodies for initial screening - these are not recommended as first-line tests 1
Starting a gluten-free diet before diagnostic confirmation - this makes subsequent diagnosis extremely difficult and may require a prolonged gluten challenge 1, 2
Failing to measure total IgA - missing IgA deficiency leads to false-negative IgA-tTG results and delayed diagnosis 1, 2